Special Reports on Trastuzumab Deruxtecan
Discover the latest advancements in cancer treatment with our collection of articles and videos on trastuzumab deruxtecan, a promising targeted therapy changing the landscape for patients with HER2-positive cancers.
Markings
Shape
Form
Color 1
Color 2
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in